Cyp1a2 - cytochrome P450, family 1, subfamily a, polypeptide 2 Gene
Also Known as CYPD45; P-450d; RATCYPD45
Species: Rattus norvegicus
Summary
Enables oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen. Involved in several processes, including cellular response to copper ion; response to estradiol; and response to lipopolysaccharide. Located in intracellular membrane-bounded organelle. Biomarker of mental depression. Human ortholog(s) of this gene implicated in breast cancer; chronic obstructive pulmonary disease; endometrial cancer; and porphyria cutanea tarda. Orthologous to human CYP1A2 (Cytochrome P450 family 1 subfamily A member 2). [provided by Alliance of Genome Resources, Apr 2022]
Cyp1a2 Products (1)
| mRNA | Protein | Name |
|---|---|---|
| NM_012541.3 | NP_036673.3 | cytochrome P450 1A2 |
| Protein Preferred Names | Protein Names | |
|---|---|---|
|
cytochrome P450 1A2 |
|
|
Related Agents
- Clinical Phase
- Pre-clinical Phase
Clinical Phase
| Cat. No. | Product Name |
Effect
|
Purity |
Phase
|
|---|---|---|---|---|
| HY-132845 | Utreloxastat | Inhibitor | 99.32% | Phase 2 |
| HY-19397 | BMS-223131 | Inhibitor | / | Phase 2 |
Pre-clinical Phase
| Cat. No. | Product Name |
Effect
|
Purity |
Rare Diseases
|
|---|---|---|---|---|
| HY-120717 | VU6001966 | Inhibitor | 99.89% | Unkown |
| HY-170846 | FGFRs-IN-1 | Inhibitor | / | Unkown |
| HY-174417 | NNRT-IN-10 | Inhibitor | / | Unkown |
| HY-167632 | meso-Zeaxanthin | Inhibitor | 93.09% | Unkown |
Compound Screening Libraries
Virtual Screening
Customize Your Library
Drug Screening Service